Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Octo is a U.S. technology consulting and IT modernization company focused on serving federal government agencies. The company became widely known for work in agile software development, DevSecOps, cloud engineering, artificial intelligence, cybersecurity, data science, open-source software, and digital transformation for defense, civilian, and health-related government customers. Originally founded as Octo Consulting Group, the company formally rebranded to "Octo" in 2020 after integrating Connexta. IBM announced its acquisition of Octo in December 2022, and the company now operates as "Octo, an IBM Company." Octo is not a biotech, pharma, or healthcare therapeutics company and does not appear to develop drug pipelines or clinical-stage assets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Octo Consulting Group.